Edesa Biotech Inc (EDSA)
1.85
+0.04
(+2.21%)
USD |
NASDAQ |
Dec 27, 16:00
1.85
0.00 (0.00%)
After-Hours: 20:00
Edesa Biotech Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | -10.57M |
| Lexaria Bioscience Corp | -0.0696M |
| Xenon Pharmaceuticals Inc | 1.98M |
| ESSA Pharma Inc | 21.02M |
| ImmunoPrecise Antibodies Ltd | -0.0482M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.967M |
| Cash from Financing (Quarterly) | -0.0314M |
| Free Cash Flow | -4.890M |
| Free Cash Flow Per Share (Quarterly) | -0.2978 |
| Free Cash Flow Yield | -82.67% |